首页> 美国卫生研究院文献>Respiratory Medicine Case Reports >Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: A case report
【2h】

Idiopathic pulmonary fibrosis patient supported with extracorporeal membrane oxygenation for 403 days while waiting for a lung transplant: A case report

机译:特发性肺纤维化患者在等待肺移植期间接受体外膜氧合支持403天:一例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

According to the Extracorporeal Life Support Organization, the average duration of veno-venous extracorporeal membrane oxygenation (V-V ECMO) in adults with acute respiratory failure is 10.5–13.5 days. Some patients on V-V ECMO may not recover in such a short period of time, and recently, there have been more reports of prolonged V-V ECMO. However, we do not know how long it is feasible to wait for native lung recovery or lung transplant (LTx) with the use of ECMO. We describe a patient with acute exacerbation of idiopathic pulmonary fibrosis supported by ECMO for 403 days while waiting for a LTx. In this case, we kept the patient awake, and he was communicating frequently with his family. We changed the membrane oxygenator 23 times and the cannula 10 times without complication. However, we terminated the treatment on day 403 of ECMO because there was no access site for cannula insertion due to blockage by a venous thrombotic occlusion, making it impossible to continue this bridge to lung transplantation. It has become possible to maintain patients on ECMO for extended periods of time, but it is difficult to manage ECMO for more than one year without the development of a more durable lung support system.
机译:根据体外生命支持组织的资料,患有急性呼吸衰竭的成年人平均静脉-静脉体外膜氧合作用(V-V ECMO)持续时间为10.5-13.5天。一些接受V-V ECMO的患者可能无法在这么短的时间内恢复,最近,有更多关于V-V ECMO延长的报道。但是,我们不知道使用ECMO等待自然肺恢复或肺移植(LTx)可行的时间。我们描述了一名患者,在等待LTx的同时,由ECMO支持了403天的特发性肺纤维化急性加重。在这种情况下,我们让患者保持清醒,并且他经常与家人交流。我们将膜充氧器更换了23次,将插管更换了10次,而没有发生任何并发症。但是,我们在ECMO的第403天终止了治疗,因为由于静脉血栓栓塞的阻塞而没有套管插入的进入位点,因此无法继续通往肺移植的桥梁。使患者长期使用ECMO成为可能,但如果不开发更耐用的肺部支持系统,则很难对ECMO进行超过一年的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号